Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:1
  • preuzimanja u poslednjih 30 dana:1
članak: 3 od 13  
Back povratak na rezultate
Vojnosanitetski pregled
2018, vol. 75, br. 2, str. 167-176
jezik rada: engleski
vrsta rada: izvorni naučni članak
doi:10.2298/VSP160304234V

Creative Commons License 4.0
Udruženost serumske koncentracije paratireoidnog hormona i ejekcione frakcije leve komore, markera srčane insuficijencije i inflamacije u akutnom infarktu miokarda sa ST elevacijom lečenim primarnom perkutanom koronarnom intervencijom
aMilitary Medical Academy, Clinic for Urgent Internal Medicine, Belgrade + University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade
bMilitary Medical Academy, Institute of Medical Biochemistry, Belgrade

e-adresa: svukotic72@gmail.com

Sažetak

Uvod/Cilj. U prethodnim studijama pokazano je povećanje serumske koncentracije paratireoidnog hormona (PTH) u akutnom infarktu miokarda i srčanoj insuficijenciji. U ovom istraživanju ispitali smo odnos između paratireoidnog statusa i biohemijskih, elektrokardiografskih i ehokardiografskih pokazatelja veličine infarkta i srčane insuficijencije. Metode. Kod 390 bolesnika sa akutnim infarktom miokarda sa elevacijom ST segmenta (STEMI), prosečne dobi 62 ± 12 godine, učinjene su laboratorijske analize serumske koncentracije kreatin kinaza MB frakcije (CK-MB), C-reaktivnog proteina (CRP) i intaktnog PTH i koncentracija u plazmi moždanog natriuretskog peptide (BNP) tokom prva tri dana od prijema. Svi bolesnici su lečeni primarnom perkutanom koronarnom intervencijom (PKI). Bolesnici sa težom bubrežnom insuficijencijom isključeni su iz studije (klirens kreatinina ≤ 30 mL/min). Serumska koncentracija PTH određivana je prvog, drugog i, u nekim slučajevima, trećeg dana posle prijema i najveća dobijena koncentracija je uzeta za analizu. Kohorta bolesnika je podeljena u četiri grupe na osnovu kvartila maksimalne izmerene serumske koncentracije PTH (I ≤ 4.4 pmol/L; II > 4.4 pmol/L i < 6.3 pmol/L; III ≥ 6.3 pmol/L i < 9.2 pmol/L; IV ≥ 9.2 pmol/L). Selvesterov EKG skor, ejekciona frakcija leve komore (EFLK), i indeks pokretljivosti zidova leve komore (WMSI) su određivani na otpustu bolesnika, između 5-14 dana hospitalizacije. Rezultati. Ustanovljeno je da se na otpustu EFLK statistički značajno smanjuje (p < 0.001), WMSI i EKG Selvesterov skor statistički značajno povećavaju sa većim kvartilima PTH max. koncentracije (p < 0.001 za oba parametra). BNP, CRP i CK-MB nivoi značajno se povećavaju sa većim kvartilima max. koncentracije PTH (p < 0.001; p < 0.001 p = 0.004, retrospektivno). Zaključak. Bolesnici u četvrtom kvartilu PTH imaju manju EFLK i veći Selvesterov EKG skor i WMSI od ostalih bolesnika. Ovi bolesnici takođe imaju i značajno veču koncentraciju BNP, CRP i CK-MB u ranoj fazi akutnog infarkta miokarda sa ST elevacijom (STEMI).

Ključne reči

Reference

*** (1985) The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med, 312(14): 932-6
Arakawa, N., Nakamura, M., Aoki, H., Hiramori, K. (1994) Relationship between plasma level of brain natriuretic peptide and myocardial infarctsize. Cardiology, 85, str. 334-40
Ballen, K.K., Shpall, E.J., Avigan, D., Yeap, B.Y., Fisher, D.C., McDermott, K., Dey, B.R., Attar, E., McAfee, S., Konopleva, M., Antin, J.H., Spitzer, T.R. (2007) Phase I Trial of Parathyroid Hormone to Facilitate Stem Cell Mobilization. Biology of Blood and Marrow Transplantation, 13(7): 838-843
Brunner, S., Weinberger, T., Huber, B.C., Segeth, A., Zaruba, M.-M., Theiss, H.D., Assmann, G., Herbach, N., Wanke, R., Mueller-Hoecker, J., Franz, W.-M. (2012) The cardioprotective effects of parathyroid hormone are independent of endogenous granulocyte-colony stimulating factor release. Cardiovascular Research, 93(2): 330-339
Burns, R.J., Gibbons, R.J., Yi, Q., Roberts, R.S., Miller, T.D., Schaer, G.L., Anderson, J.L., Yusuf, S. (2002) The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. Journal of the American College of Cardiology, 39(1): 30-36
Carlstedt, F., Lind, L., Wide, L., Lindahl, B., Hanni, A., Rastad, J., Ljunghall, S. (1997) Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. European Journal of Clinical Investigation, 27(12): 977-981
Christenson, R.H., Vollmer, R.T., Ohman, E., Peck, S., Thompson, T.D., Duh, S., Ellis, S.G., Newby, L., Topol, E.J., Califf, R.M. (2000) Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction∗∗A complete list of the TAMI Study Group appears in J Am Coll Cardiol 1992;19:482-489. American Journal of Cardiology, 85(5): 543-547
Clemens, T.L., Cormier, S., Eichinger, A., Endlich, K., Fiaschi-Taesch, N., Fischer, E., Friedman, P.A., Karaplis, A.C., Massfelder, T., Rossert, J., Schlüter, K., Silve, C., Stewart, A.F. (2001) Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. British Journal of Pharmacology, 134(6): 1113-1136
Conway, D.R., Kim, D., Djuricin, G., Vandenburgh, A., Jacobs, H.K., Rosel, T.J., i dr. (1990) The effect of parathyroid hormone on the acutely ischemic myocardium. Am Surg, 56(8): 463-7
Dagres, N., Hindricks, G. (2013) Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?. European Heart Journal, 34(26): 1964-1971
Damman, P., Beijk, M.A.M., Kuijt, W.J., Verouden, N.J.W., van Geloven, N., Henriques, J.P.S., Baan, J., Vis, M.M., Meuwissen, M., van Straalen, J.P., Fischer, J., Koch, K.T., Piek, J.J., Tijssen, J.G.P., de W (2011) Multiple Biomarkers at Admission Significantly Improve the Prediction of Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology, 57(1): 29-36
Eek, C., Grenne, B., Brunvand, H., Aakhus, S., Endresen, K., Hol, P.K., Smith, H.-J., Smiseth, O.A., Edvardsen, T., Skulstad, H. (2010) Strain Echocardiography and Wall Motion Score Index Predicts Final Infarct Size in Patients With Non-ST-Segment-Elevation Myocardial Infarction. Circulation: Cardiovascular Imaging, 3(2): 187-194
Gensure, R.C., Gardella, T.J., Jüppner, H. (2005) Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochemical and Biophysical Research Communications, 328(3): 666-678
Grande, P., Hansen, B.F., Christiansen, C., Naestoft, J. (1982) Estimation of acute myocardial infarct size in man by serum CK-MB measurements. Circulation, 65(4): 756-764
Hashimoto, K., Nakagawa, Y., Shibuya, T., Satoh, H., Ushijima, T., Imai, S. (1981) Effects of Parathyroid Hormone and Related Polypeptides on the Heart and Coronary Circulation of Dogs. Journal of Cardiovascular Pharmacology, 3(4): 668-676
Hebden, R.A., Nathan, H.J. (1994) Effect of parathyroid hormone on myocardial blood flow and infarct size following coronary artery occlusion in the dog. Can J Cardiol, 10(4): 477-83
Huber, B.C. (2014) Impact of parathyroid hormone on bone marrow-derived stem cell mobilization and migration. World Journal of Stem Cells, 6(5): 637
Joborn, H., Hjemdahl, P., Larsson, F. T., Lithell, H., Lundin, L., Wide, L., Ljunghall, S. (1990) Platelet and Plasma Catecholamines in Relation to Plasma Minerals and Parathyroid Hormone Following Acute Myocardial Infarction. Chest, 97(5): 1098-1105
Lagrand, W.K., Niessen, H.W.M., Wolbink, G.-J., Jaspars, L.H., Visser, C.A., Verheugt, F.W.A., Meijer, C.J.L.M., Hack, C.E. (1997) C-Reactive Protein Colocalizes With Complement in Human Hearts During Acute Myocardial Infarction. Circulation, 95(1): 97-103
Loring, Z., Chelliah, S., Selvester, R.H., Wagner, G., Strauss, D.G. (2011) A detailed guide for quantification of myocardial scar with the Selvester QRS score in the presence of electrocardiogram confounders. Journal of Electrocardiology, 44(5): 544-554
Ljunghall, S., Lundin, L., Hvarfner, A., Joborn, H., Wide, L. (2009) Serum Electrolytes and Parathyroid Hormone Concentrations in Acute Myocardial Infarction. Experimental and Clinical Endocrinology & Diabetes, 88(04): 95-100
Ljunhgall, S., Åkerström, G., Benson, L., Hetta, J., Rudberg, C., Wide, L. (2009) Effects of Epinephrine and Norepinephrine on Serum Parathyroid Hormone and Calcium in Normal Subjects. Experimental and Clinical Endocrinology & Diabetes, 84(06): 313-318
Møller, J.E., Hillis, G.S., Oh, J.K., Reeder, G.S., Gersh, B.J., Pellikka, P.A. (2006) Wall motion score index and ejection fraction for risk stratification after acute myocardial infarction. American Heart Journal, 151(2): 419-425
Nienhuis, M.B., Ottervanger, J.P., de Boer, M., Dambrink, J.E., Hoorntje, J.C.A., Gosselink, A.T. M., Suryapranata, H., vant Hof, A.W.J. (2008) Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction. American Heart Journal, 155(4): 673-679
Nikfardjam, M., Mullner, M., Schreiber, W., Oschatz, E., Exner, M., Domanovits, H., Laggner, A.N., Huber, K. (2000) The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction. Journal of Internal Medicine, 247(3): 341-345
Ogino, K., Burkhoff, D., Bilezikian, J.P. (1995) The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology, 136(7): 3024-3030
Ohlmann, P., Jaquemin, L., Morel, O., el Behlgiti, R., Faure, A., Michotey, M., Beranger, N., Roul, G., Schneider, F., Bareiss, P., Monassier, J. (2006) Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction. American Heart Journal, 152(6): 1161-1167
Ortolani, P., Marzocchi, A., Marrozzini, C., Palmerini, T., Saia, F., Taglieri, N., Baldazzi, F., Silenzi, S., Bacchi-Reggiani, M.L., Guastaroba, P., Grilli, R., Branzi, A. (2007) Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. European Heart Journal, 29(10): 1241-1249
Pride, Y.B., Giuseffi, J.L., Mohanavelu, S., Harrigan, C.J., Manning, W.J., Gibson, C. M., Appelbaum, E. (2010) Relation Between Infarct Size in ST-Segment Elevation Myocardial Infarction Treated Successfully by Percutaneous Coronary Intervention and Left Ventricular Ejection Fraction Three Months After the Infarct. American Journal of Cardiology, 106(5): 635-640
Reeder, G.S., Holmes, D.R., Detre, K., Costigan, T., Kelsey, S.F. (1988) Degree of revascularization in patients with multivessel coronary disease: a report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation, 77(3): 638-644
Richards, A., Nicholls, M., Espiner, E.A., Lainchbury, J.G., Troughton, R.W., Elliott, J., Frampton, C., Turner, J., Crozier, I.G., Yandle, T.G. (2003) B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation, 107(22): 2786-92
Roubin, G.S., Shen, W.F., Kelly, D.T., Harris, P.J. (1983) The QRS scoring system for estimating myocardial infarct size: Clinical, angiographic and prognostic correlations. Journal of the American College of Cardiology, 2(1): 38-44
Rouleau, J., Packer, M., Moyé, L., de Champlain, J., Bichet, D., Klein, M., Rouleau, J.R., Sussex, B., Arnold, J., Sestier, F., Parker, J.O., McEwan, P., Bernstein, V., Cuddy, T. (1994) Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: Effect of captopril. Journal of the American College of Cardiology, 24(3): 583-591
Sanchis, J., Bodí, V., Llácer, À., Núñez, J., Facila, L., Ruiz, V., Blasco, M., Sanjuán, R., Chorro, F.J. (2004) Usefulness of C-reactive protein and left ventricular function for risk assessment in survivors of acute myocardial infarction. American Journal of Cardiology, 94(6): 766-769
Sano, T., Tanaka, A., Namba, M., Nishibori, Y., Nishida, Y., Kawarabayashi, T., Fukuda, D., Shimada, K., Yoshikawa, J. (2003) C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation, 108(3): 282-5
Schluter, K.D., Piper, H.M. (1998) Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res, 37(1): 34-41
Shah, J.H., Motto, G.S., Kukreja, S.C., Hargis, G.K., Williams, G.A. (1975) Stimulation of the Secretion of Parathyroid Hormone During Hypoglycemic Stress. Journal of Clinical Endocrinology & Metabolism, 41(4): 692-696
Sugimoto, T., Dohi, K., Onishi, K., Yamada, T., Horiguchi, M., Takamura, T., Kawamura, A., Seko, T., Nakamura, M., Kasai, A., Ito, M. (2014) Prognostic Value of Serum Parathyroid Hormone Level in Acute Decompensated Heart Failure. Circulation Journal, 78(11): 2704-2710
Tastan, I., Schreckenberg, R., Mufti, S., Abdallah, Y., Piper, H.M., Schluter, K.-D. (2009) Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way. Cardiovascular Research, 82(1): 77-83
Tjandrawidjaja, M.C., Fu, Y., Westerhout, C.M., Wagner, G.S., Granger, C.B., Armstrong, P.W. (2010) Usefulness of the QRS Score as a Strong Prognostic Marker in Patients Discharged After Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. American Journal of Cardiology, 106(5): 630-634
Toth, M., Vuorinen, K.H., Vuolteenaho, O., Hassinen, I.E., Uusimaa, P.A., Leppaluoto, J., Ruskoaho, H. (1994) Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol, 266(4 Pt 2): H1572-80
Velders, M.A., Wallentin, L., Becker, R.C., van Boven, A.J., Himmelmann, A., Husted, S., Katus, H.A., Lindholm, D., Morais, J., Siegbahn, A., Storey, R.F., Wernroth, L., James, S.K. (2015) Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial. American Heart Journal, 169(6): 879-889.e7
Zaruba, M., Huber, B.C., Brunner, S., Deindl, E., David, R., Fischer, R., Assmann, G., Herbach, N., Grundmann, S., Wanke, R., Mueller-Hoecker, J., Franz, W. (2007) Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival. Cardiovascular Research, 77(4): 722-731